Sector Update: Healthcare
Healthcare shares are flat in pre-market trade.
Pharmaceutical company Allergan, Inc. ( AGN ) has been upgraded by analysts at Wells Fargo to Outperform from Market Perform. The firm raised its price target range to $121-$122 from $99-$100.
In the pre-market session, shares of AGN were level at $107.39, within a 52-week spread of $81.33 - $116.45.
The company says it is now actively pursuing its patent Assertion Programme in USA, and says several "significant cases" are now pending in the District of Delaware - including cases against Bristol Myers Squibb ( BMY ) and Pfizer ( PFE ).